<DOC>
	<DOCNO>NCT02596321</DOCNO>
	<brief_summary>To demonstrate superiority ALK HDM tablet versus placebo immune response , measure change D.farinae specific immunoglobulin G4 ( IgG4 ) baseline end treatment ALK HDM tablet give daily 60 day .</brief_summary>
	<brief_title>A Study Investigating Immunologic Effects Safety 60-day Treatment ALK-Abello A/S , Originator ALK HDM Tablets Adult Subjects With Allergic Rhinitis and/or Atopic Asthma Induced House Dust Mites ( HDM )</brief_title>
	<detailed_description>To demonstrate superiority ALK HDM tablet versus placebo immune response , measure change D. Farinae specific IgG4 baseline end treatment ALK HDM tablet give daily 60 day To evaluate immune response , measure change D. pteronyssinus , D. farinae specific immunoglobulin E ( IgE ) D. pteronyssinus specific IgG4 baseline end treatment ALK HDM tablet give daily 60 day , compare placebo To evaluate patient HDM-allergic respiratory disease safety tolerability 60-day treatment ALK HDM tablet compare placebo</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Written inform consent obtain enter study Patients 1865 year age , clinical history consistent HDMinduced allergic rhinitis allergic rhinoconjunctivitis without HDMinduced allergic atopic asthma 1 year Use symptomatic treatment HDMinduced allergic rhinitis and/or HDMinduced atopic asthma , i.e . antihistamine , nasal decongestant , nasal and/or inhale corticosteroid 1 year HDMinduced atopic asthma present , mild moderate severity , control treatment correspond step 13 The Global initiative asthma ( GINA ) Positive skin prick test response ( wheal diameter ≥3 mm ) D pteronyssinus and/or D.farinae Moderate high level D.pteronyssinus and/or D.farinae specific IgE ( define ≥IgE Class 2 ; ≥0.70 kilo unit ( kU ) /L ) Patient one following : 1 . Male 2 . Female , infertile 3 . Female , negative pregnancy test willingness practice appropriate contraceptive method treatment study drug discontinue . Patient willing able comply study protocol Previous treatment HDM immunotherapy 1 month within last 5 year Ongoing treatment allergenspecific immunotherapy product Reduced lung function ( define Forced expiratory volume 1 second ( FEV1 ) &lt; 70 % predict value adequate pharmacologic treatment ) measure Visit 1 Visit 2 Clinical history uncontrolled asthma within 3 month prior screen visit Having experience severe asthma exacerbation within 3 month prior screen visit Symptoms treatment upper respiratory tract infection , acute sinusitis , acute otitis medium relevant infectious process randomization Inflammatory condition oral cavity severe symptom oral lichen planus ulceration severe oral mycosis randomization History anaphylaxis cardiorespiratory symptom ( immunotherapy , exerciseinduced , food allergy , drug idiopathic reaction ) History recurrent generalize urticaria ( define two episode ) last 2 year A history drug induce ( incl . immunotherapy ) facial angioedema family ( parent sibling ) history hereditary angioedema Any chronic disease ( e.g . cystic fibrosis , malignancy , malabsorption malnutrition , renal hepatic abnormality diseases opinion investigator would interfere study evaluation safety subject ) Systemic disease affect immune system ( e.g . autoimmune disease , immune complex disease , immune deficiency disease whether acquire ) Immunosuppressive treatment ( ATC code L04 L01 ) within 3 month prior screen visit Currently treat tricyclic antidepressant ; catecholamineOmethyltransferase ( COMT ) inhibitor mono amine oxidase inhibitor ( MAOIs ) betablockers include topical administration Use medication screen visit time skin prick test ( SPT ) interfere result ( i.e . antihistamine ) Use investigational drug within 30 days/5 halflives drug ( ever long ) prior screen visit History allergy , hypersensitivity intolerance excipient investigational medicinal product ( except D.Pteronyssinus D.farinae ) Being immediate family investigator study staff , define investigator's/staff 's spouse , parent , child , grandparent grandchild Severe mental disorder opinion investigator would interfere study evaluation safety subject Cardiovascular condition complication possible use adrenaline Women pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>House Dust Mite</keyword>
</DOC>